13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 27 holding rows worth $495,010,000.
- Accession
- 0000921895-15-002554
- Filer
- CIK 1056807
- Filed
- 2015-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 27 entries on the cover page, a total value of $495,010,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $495,010,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,874,373 | $50,791,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 7,573,493 | $45,820,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 16,360,538 | $44,828,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 9,680,630 | $44,144,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,255,168 | $42,330,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,702,654 | $36,335,000 | thousands by filing date | |
| EXELIXIS INC | 30161QAC8 | NOTE 4.250% 8/1 | 27,239,000 | $33,010,000 | thousands by filing date | principal |
| LOXO ONCOLOGY INC | 548862101 | COM | 1,531,108 | $26,764,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 2,375,933 | $26,159,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 1,016,324 | $23,945,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,376,113 | $22,830,000 | thousands by filing date | |
| CTI BIOPHARMA CORP COM NEW | 12648L106 | Stock | 10,000,000 | $14,600,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,106,989 | $14,096,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 6,566,148 | $12,279,000 | thousands by filing date | |
| TOBIRA THERAPEUTICS INC COM | 88883P101 | COM | 1,175,233 | $11,353,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 3,737,446 | $9,942,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,035,572 | $8,554,000 | thousands by filing date | |
| GTX INC | 40052B108 | COM | 10,772,306 | $8,187,000 | thousands by filing date | |
| CATALYST | 14888D109 | COM | 1,020,874 | $4,757,000 | thousands by filing date | |
| MAST THERAPEUTICS INC | 576314108 | COM | 5,104,068 | $2,960,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 456,500 | $2,479,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 2,500,000 | $2,477,000 | thousands by filing date | principal |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 2,500,000 | $2,025,000 | thousands by filing date | |
| GLOBEIMMUNE INC | 37957B100 | COM | 678,400 | $1,771,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 928,760 | $1,700,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 350,776 | $695,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 41,600 | $179,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-15-002554 | this filing | 2015-11-16 | acceptance time not in the bulk data set |